🟢 Senti Biosciences is trading 6.65% up in after-hours trading after a sector-driven recovery

Senti Biosciences is trading 6.65% up now at $0.47 after recovering from its 5.83% regular-session decline to $0.44 on August 20, 2026; the move appears sector-driven.

• Biotech shares broadly weakened as Moderna reversed part of its historic cancer-vaccine rally.
• The XBI biotech ETF was down 3.24% during Thursday’s session.
• No new Senti-specific announcement was identified for August 20, 2026.